Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-26 11:52 am Unchanged | 2026-03-13 | 13G | NovoCure Limited NVCR | VANGUARD GROUP INC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2026-02-12 5:01 pm Sale | 2025-12-31 | 13G | NovoCure Limited NVCR | Soleus Capital Master Fund, L.P. | 8,530,665 7.600% | -1,114,207 (-11.55%) | Filing History |
| 2025-11-13 7:06 pm Sale | 2025-09-30 | 13G | NovoCure Limited NVCR | Capital World Investors | 2,000,000 1.800% | -4,382,848 (-68.67%) | Filing History |
| 2025-11-07 4:00 pm Purchase | 2025-09-30 | 13G | NovoCure Limited NVCR | Soleus Capital Master Fund, L.P. | 9,644,872 8.600% | 2,740,570 (+39.69%) | Filing History |
| 2025-08-13 12:56 pm Purchase | 2025-06-30 | 13G | NovoCure Limited NVCR | Capital World Investors | 6,382,848 5.700% | 6,382,848 (New Position) | Filing History |
| 2025-08-05 5:00 pm Purchase | 2025-06-30 | 13G | NovoCure Limited NVCR | Soleus Capital Master Fund, L.P. | 6,904,302 6.200% | 1,382,888 (+25.05%) | Filing History |
| 2025-07-07 1:42 pm Unchanged | 2025-06-30 | 13G | NovoCure Limited NVCR | Capital International Investors | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-04-23 8:00 pm Purchase | 2025-03-31 | 13G | NovoCure Limited NVCR | BlackRock Inc. BLK | 9,083,620 8.300% | 9,083,620 (New Position) | Filing History |
| 2025-04-01 5:00 pm Purchase | 2025-03-31 | 13G | NovoCure Limited NVCR | Soleus Capital Master Fund, L.P. | 5,521,414 5.000% | 5,521,414 (New Position) | Filing History |
| 2024-07-10 1:14 pm Unchanged | 2024-07-10 | 13G | NovoCure Limited NVCR | VANGUARD GROUP INC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-07-08 4:32 pm Unchanged | 2024-07-08 | 13G | NovoCure Limited NVCR | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-13 5:09 pm Unchanged | 2024-02-13 | 13G | NovoCure Limited NVCR | VANGUARD GROUP INC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-09 6:14 pm Unchanged | 2024-02-09 | 13G | NovoCure Limited NVCR | Capital World Investors | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-09 6:03 pm Unchanged | 2024-02-09 | 13G | NovoCure Limited NVCR | Capital International Investors | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-09 11:32 am Unchanged | 2024-02-09 | 13G | NovoCure Limited NVCR | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-09 09:28 am Unchanged | 2024-02-09 | 13G | NovoCure Limited NVCR | FMR LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-12-11 06:19 am Unchanged | 2023-12-11 | 13G | NovoCure Limited NVCR | Capital World Investors | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-11-09 06:15 am Unchanged | 2023-11-09 | 13G | NovoCure Limited NVCR | BAILLIE GIFFORD & CO | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-13 3:54 pm Unchanged | 2023-02-13 | 13G | NovoCure Limited NVCR | Capital International Investors | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-13 2:49 pm Unchanged | 2023-02-13 | 13G | NovoCure Limited NVCR | Capital World Investors | 0 0.000% | 0 (Unchanged) | Filing |